Therapy-related issues: respiratory system

Author(s):  
Philip Wiffen ◽  
Marc Mitchell ◽  
Melanie Snelling ◽  
Nicola Stoner

This chapter outlines information relevant to clinical pharmacists related to respiratory system issues and is loosely based on the British National Formulary, Chapter 3. In particular, this chapter covers current guidelines on asthma management, including a section on inhaler techniques for different products, and management of stable chronic obstructive pulmonary disease.

Author(s):  
Murray Longmore ◽  
Ian B. Wilkinson ◽  
Andrew Baldwin ◽  
Elizabeth Wallin

Signs:Examining the respiratory system –Investigations:Bedside tests in chest medicineFurther investigations in chest medicinePulmonary conditions:PneumoniaSpecific pneumoniasComplications of pneumoniaBronchiectasisCystic fibrosis (cf)Fungi and the lungLung tumoursAsthmaManagement of chronic asthmaChronic obstructive pulmonary disease (...


Author(s):  
Chantal Simon ◽  
Hazel Everitt ◽  
Françoise van Dorp ◽  
Matt Burkes

Breathlessness Cough Chest signs Other signs of respiratory disease Respiratory investigations Bronchodilators and steroids Asthma in adults Asthma management in practice Drug treatment of asthma Chronic obstructive pulmonary disease Management of COPD Acute exacerbations of COPD Lung cancer Colds and influenza Pneumonia in adults Tuberculosis...


2019 ◽  
Vol 8 (1) ◽  
pp. 69 ◽  
Author(s):  
Frederik Trinkmann ◽  
Joachim Saur ◽  
Martin Borggrefe ◽  
Ibrahim Akin

In patients with chronic obstructive pulmonary disease (COPD), cardiovascular comorbidities are highly prevalent and associated with considerable morbidity and mortality. This coincidence is increasingly seen in context of a “cardiopulmonary continuum” rather than being simply attributed to shared risk factors such as cigarette smoking. Overlapping symptoms such as dyspnea or chest pain lead to a worse prognosis due to missed concomitant diagnoses. Moreover, medication is often withheld as a result of unfounded concerns about side effects. Despite the frequent coincidence, current guidelines are still mostly restricted to the management of the individual disease. Future diagnostic and therapeutic strategies should therefore be guided by an integrative perspective as well as a refined phenotyping of disease entities.


2013 ◽  
Vol 187 (12) ◽  
pp. 1315-1323 ◽  
Author(s):  
Roberto C. Chin ◽  
Jordan A. Guenette ◽  
Sicheng Cheng ◽  
Natya Raghavan ◽  
Naparat Amornputtisathaporn ◽  
...  

2020 ◽  
Vol 27 (4) ◽  
pp. 451-457
Author(s):  
Aleksey V. Kosyakov ◽  
Vladimir N. Abrosimov

Aim. To evaluate changes in the cardiointervalogram (CIG) in the test with external peripheral vascular occlusion in patients with chronic obstructive pulmonary disease (COPD) and in individuals without diseases of the respiratory system. Materials and Methods. The study included 105 men, of them 64 patients with COPD (age 64.988.67) and 41 volunteers without diseases of the respiratory system (age 61.689.21). The autonomic status was examined and alterations in CIG in the test with occlusion were evaluated on Varicard hardware and software complex (OOO Ramena, Russia). Results. The obtained data showed the autonomic imbalance with predomination of the activity of sympathetic division of the autonomic nervous system (ANS) in patients with COPD as compared to the control group (p0.05). A study of ergoreflex by analysis of changes in CIG showed reduction of the activity of sympathetic division of the ANS in the test with external peripheral vascular occlusion in individuals without diseases of the respiratory system. In patients with COPD, changes in CIG in the test were less expressed and not always achieved statistically significant level (p0.05). Conclusions. Differences in the results of the test with external peripheral vascular occlusion in patients with COPD and volunteers without diseases of the respiratory system are attributed to hyperactivation of ergofeflex in patents with COPD.


2021 ◽  
Vol 8 (8) ◽  
pp. 1154
Author(s):  
Suresh Chandravanshi ◽  
Mahesh Kumar Sharma ◽  
D. P. Lakra ◽  
Manisha Khande ◽  
R. K. Panda

Background: The study aimed to assess the magnitude of asthma chronic obstructive pulmonary disease asthma chronic obstructive (ACO) in patients with chronic airway disease.Methods: The study was conducted as cross-sectional study on patients with chronic airway disease presenting at our institute during the study period of 1 year. Global initiative for asthma management and prevention (GINA) syndromic approach table was used to diagnose patients with chronic airways disease. Syndromic and confirmatory diagnosis of ACO was made based upon clinical features and spirometry respectively.Results: About 73.6% were diagnosed as chronic obstructive pulmonary disease (COPD) and 26.4% cases were diagnosed as asthma. Overall ACO was present in 20% cases. ACO was significantly associated with advancing age, male gender, and longer duration of smoking (p<0.05) in asthma patients whereas in COPD patients ACO was associated with advancing age (p<0.05).Conclusions: Overall one fifth of the patients with chronic airway disease have asthma COPD overlap. The ACO is observed in almost equal proportions in asthma and COPD. ACO prevalence was found to increase with age in patients with asthma and COPD.


2019 ◽  
Vol 126 (5) ◽  
pp. 1223-1231 ◽  
Author(s):  
Stephen Milne ◽  
Kanika Jetmalani ◽  
David G. Chapman ◽  
Joseph M. Duncan ◽  
Claude S. Farah ◽  
...  

Respiratory system reactance (Xrs) measured by the forced oscillation technique (FOT) is theoretically and experimentally related to lung volume. In chronic obstructive pulmonary disease (COPD), the absolute volume measured by body plethysmography includes a proportion that is inaccessible to pressure oscillations applied via the mouth, that is, a “noncommunicating” lung volume. We hypothesized that in COPD the presence of noncommunicating lung would disrupt the expected Xrs-volume relationship compared with plethysmographic functional residual capacity (FRCpleth). Instead, Xrs would relate to estimates of communicating volume, namely, expiratory reserve volume (ERV) and single-breath alveolar volume (VaSB). We examined FOT and lung function data from people with COPD ( n = 51) and from healthy volunteers ( n = 40). In healthy volunteers, we observed an expected inverse relationship between reactance at 5 Hz (X5) and FRCpleth. In contrast, there was no such relationship between X5 and FRCpleth in COPD subjects. However, there was an inverse relationship between X5 and both ERV and VaSB. Hence the theoretical Xrs-volume relationship is present in COPD but only when considering the communicating volume rather than the absolute lung volume. These findings confirm the role of reduced communicating lung volume as an important determinant of Xrs and therefore advance our understanding and interpretation of FOT measurements in COPD. NEW & NOTEWORTHY To investigate the determinants of respiratory system reactance (Xrs) measured by the forced oscillation technique (FOT) in chronic obstructive pulmonary disease (COPD), we examine the relationship between Xrs and lung volume. We show that Xrs does not relate to absolute lung volume (functional residual capacity) in COPD but instead relates only to the volume of lung in communication with the airway opening. This communicating volume may therefore be fundamental to our interpretation of FOT measurements in COPD and other pulmonary diseases.


Sign in / Sign up

Export Citation Format

Share Document